The imperative to enhance access to quality care and research is a central concern gripping both the healthcare and pharmaceutical sectors. At the heart of this challenge lies the crucial necessity for clean and streamlined patient data, which currently suffers from inadequacies in comprehensiveness and accuracy. Addressing this pivotal issue carries immense benefits, particularly in the sphere of targeted trial recruitment efforts. By harnessing better patient data records, the possibilities
Read More
Decentralized Clinical Trials
How to Achieve Health Equity in Decentralized Clinical Trials
Trial sponsors have made efforts to address underrepresentation and promote Diversity, Equity and Inclusion (DEI) in clinical trials since the Federal and Drug Administration’s (FDA) 2016 guidance, but a new report released by the Government Accountability Office (GAO) still shows a continuous presence of major gaps in patient diversity. It begs the question: how do we ultimately achieve full representation and ensure accountability to uphold the promises we have made for
Read More
Walgreens and Freenome Partner to Increase Diversity in Research
What You Should Know: Walgreens and Freenome form a multi-year relationship to advance clinical studies of Freenome’s blood-based tests for the early detection of cancer. Walgreens will combine its national footprint, patient insights, compliant recruitment technology and local infrastructure to engage diverse patient populations in Freenome’s multi-cancer research program. Walgreens will initially recruit patients across diverse populations for Freenome’s Sanderson Study, which aims to
Read More
Expectations For The Connected Care Business In The Years Ahead
Though we seldom see their use in our modern world and, even then, only in fiction, there was a time when it was common for people to actually use things like crystal balls and divining rods to try to uncover unknown yet valuable information. As unbelievable as it may seem, soothsayers peered into crystal balls aiming to help seekers look into the future for guidance, while prospectors would rely earnestly on divining rods as they attempted to locate underground riches of water or oil. While
Read More
ObvioHealth Launches Decentralized Clinical Trial for Migraine Treatment Device
What You Should Know: - ObvioHealth and Mi-Helper, Inc. announce a partnership to conduct a decentralized clinical trial for a non-invasive neuromodulation device for the treatment of migraines. The randomized controlled trial will be fully remote, enabling data capture from home—where the device is intended to be used. - Mi-Helper has been developed to meet a massive unmet need for effective, targeted, and drug-free pain management of migraines, a condition which impacts 1 billion
Read More
H1 Launches Advanced Diversity and Clinical Trial Performance Insights
What You Should Know: - H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced the availability of indication-level diversity insights in addition to institution, provider, and patient diversity data within its Trial Landscape solution. - Additionally, H1 has successfully onboarded its first customer – a top 20 pharmaceutical company – onto the H1 Data Network, a new solution that aggregates sponsor-contributed site and
Read More
Report: Pharma R&D ROI Falls to Lowest Level in 13 Years
What You Should Know: - Deloitte Centre for Health Solutions releases its thirteenth annual report, ‘Seize the Digital Momentum: Measuring the return from pharmaceutical innovation 2022’ that explores the performance of the biopharmaceutical industry (bio Pharma) and its ability to generate returns from investment in innovative new medicines. - Since 2021, much of the world has successfully adjusted to life where COVID-19 is more endemic as vaccines and treatments reduced the risk and
Read More
7 Life Sciences Executive Predictions to Watch in 2023
Tracy Curley, CFO and interim CEO at iSpecimen Focusing on the macroeconomic environment, which remains impacted by the lingering COVID-19 pandemic, there continues to be uncertainty about the strength of the global, Asia Pacific, UK and US economies. High-interest rates and a potential recession remain a concern for all market participants. At ISPC, we are closely monitoring the pace of specimen transactions. We believe that this industry can be resilient through a continued economic
Read More
HLTH22 Day 1 News Summary: Google, Maven, Highmark, LG, Others
Venture Capital, Private Equity Funding Maven Clinic Secures $90M to Advance End-to-End Family Care Platform Maven Clinic, the largest virtual clinic in women’s and family health raises $90 million Series E funding bringing its total funding to $300M. Maven plans to use the latest round of funding to advance its end-to-end family care platform to enable deeper personalization to meet the diverse needs of women and families everywhere. Curavit Raises $5M for Digital Therapeutics
Read More
HLTH22: Curavit Raises $5M for Digital Therapeutics Clinical Research
What You Should Know: - Curavit Clinical Research, a virtual contract research organization (VCRO) that specializes in decentralized clinical trials (DCTs) announced it raised $5M in Series A funding to accelerate its growing portfolio of research in the global digital therapeutics (DTx) market. The round was led by Osage Venture Partners with additional investment from Royal Street Ventures and Narrow Gauge Ventures. - The new funding will be used to expand
Read More
